Brief: Neuland Laboratories Approves Capital Expenditure Of 1.28 Billion Rupees To Enhance Unit 3 Capacity
10/11/2023 11:51
Nov 10 (Reuters) - Neuland Laboratories Ltd NEUL.NS :
* APPROVED CAPITAL EXPENDITURE OF 1.28 BILLION RUPEES FOR
ENHANCING CAPACITY AT UNIT 3
Source text for Eikon: ID:nNSE9P1x1y
Further company coverage: NEUL.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Neuland Laboratories
See all newsIndia's Neuland Laboratories jumps after approving $13.3 mln land purchase for expansion
Brief: Neuland Laboratories Approves Capital Expenditure Of 1.26 Billion Rupees For Land Purchase In Kakinada
Brief: Neuland Laboratories Says US FDA Inspects Neuland Laboratories Unit 3 From August 10 To 14, 2026
Brief: Neuland Laboratories June-Quarter Consol Profit 1.48 Billion Rupees
Brief: Neuland Laboratories March-Quarter Consol Profit 2.13 Bln Rupees